BTA biota holdings limited
Add to My Watchlist 0.00% ! 57.0¢

VamoTamiflu has (until now) become a mainstream defence against...

  1. prophet4me
    1,492 Posts.
    lightbulb Created with Sketch. 10
    clock Created with Sketch.
    25/07/09
    11:51
    Post #: 5430194
    Vamo

    Tamiflu has (until now) become a mainstream defence against influenza. Its sales up until now have not been confined to pandemics. With its resistance and side effects and a superior product emerging taking market share off Tamiflu there is no reason why Relenza will not be an ongoing referred and preferred product in the treatment of influenza.
    BTA Price at posting: $1.88 Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AFP Combogesic IV Launches in Canada and R&D Shows Significant Advances
right-arrow Created with Sketch.
NEWS Significant new gold-copper discovery at Minyari Dome delivers high-grade results
right-arrow Created with Sketch.
NEWS Outstanding Drill Results Define New High-Grade Iris Zone at Apollo Hill
right-arrow Created with Sketch.
NEWS Proteomics International granted first patent for endometriosis diagnostic blood test in Japan
right-arrow Created with Sketch.
NEWS Next Science to Sell Majority of Assets in Proposed Transaction
right-arrow Created with Sketch.
ACW Actinogen Confirms 100th Participant in Alzheimer’s Disease Trial and Interim Analysis Timeline
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.